Skip to content

Home
About Us
Oncology
Preclinical Services
Shareholders
News & Resources
Contact Us
English

Menu

Home
About Us
Oncology
Preclinical Services
Shareholders
News & Resources
Contact Us
English

Final Director's Interest Notice

January 11, 2019

Final Director’s Interest Notice
appendix3z-koh_chow-yee_jan19

Categories ASX Announcements

Post navigation

Invitrocue Appoints Professor Masakazu Toi as Clinical Advisor

Expiry of unlisted options – Jan 2019

Search for:

Recent Posts

LSCCB Symposium – May 2023
CME Talk – 17th May 2023
International MOU inked between chemistry and biomedical talents from Hong Kong, Singapore and Europe for late-stage cancer research enhancement.
Annals of Oncology – ESMO Abstract 233P
ESMO Breast Cancer 2022, Berlin, Germany

GET IN TOUCH

51 Science Park Road, #01-11/13
The Aries, Singapore Science Park II
Singapore 117586

contact@invitrocue.com

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Twitter Facebook-f Linkedin-in Youtube

© Copyright 2023 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings